Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-02-22 Sale |
2021-02-24 4:28 pm |
Blueprint Medicines Corp | BPMC | Dorsch Marion Chief Scientific Officer |
7,578 | $100 | $757,800 | 55,672 (Direct) |
View |
2020-12-14 Sale |
2020-12-16 4:03 pm |
Blueprint Medicines Corp | BPMC | Dorsch Marion Chief Scientific Officer |
4,600 | $119 | $547,400 | 63,250 (Direct) |
View |
2020-10-06 Sale |
2020-10-08 4:16 pm |
Blueprint Medicines Corp | BPMC | Dorsch Marion Chief Scientific Officer |
4,600 | $99 | $455,400 | 67,850 (Direct) |
View |
2020-09-23 Sale |
2020-09-25 4:27 pm |
Blueprint Medicines Corp | BPMC | Dorsch Marion Chief Scientific Officer |
4,600 | $89 | $409,400 | 72,450 (Direct) |
View |
2020-06-19 Sale |
2020-06-23 4:10 pm |
Blueprint Medicines Corp | BPMC | Dorsch Marion Chief Scientific Officer |
4,600 | $79 | $363,400 | 77,050 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-02-22 Exercise |
2021-02-24 4:28 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Dorsch Marion Chief Scientific Officer |
7,578 | $37.11 | 55,672 (Direct) |
View |
2021-02-22 Exercise |
2021-02-24 4:28 pm |
N/A 2026-11-21 |
Blueprint Medicines Corp | BPMC | Dorsch Marion Chief Scientific Officer |
7,578 | $0 | 55,672 (Direct) |
View |
2020-12-14 Exercise |
2020-12-16 4:03 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Dorsch Marion Chief Scientific Officer |
4,600 | $37.11 | 63,250 (Direct) |
View |
2020-12-14 Exercise |
2020-12-16 4:03 pm |
N/A 2026-11-21 |
Blueprint Medicines Corp | BPMC | Dorsch Marion Chief Scientific Officer |
4,600 | $0 | 63,250 (Direct) |
View |
2020-10-06 Exercise |
2020-10-08 4:16 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Dorsch Marion Chief Scientific Officer |
4,600 | $37.11 | 67,850 (Direct) |
View |
2020-10-06 Exercise |
2020-10-08 4:16 pm |
N/A 2026-11-21 |
Blueprint Medicines Corp | BPMC | Dorsch Marion Chief Scientific Officer |
4,600 | $0 | 67,850 (Direct) |
View |
2020-09-23 Exercise |
2020-09-25 4:27 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Dorsch Marion Chief Scientific Officer |
4,600 | $37.11 | 72,450 (Direct) |
View |
2020-09-23 Exercise |
2020-09-25 4:27 pm |
N/A 2026-11-21 |
Blueprint Medicines Corp | BPMC | Dorsch Marion Chief Scientific Officer |
4,600 | $0 | 72,450 (Direct) |
View |
2020-06-19 Exercise |
2020-06-23 4:10 pm |
N/A N/A |
Blueprint Medicines Corp | BPMC | Dorsch Marion Chief Scientific Officer |
4,600 | $37.11 | 77,050 (Direct) |
View |
2020-06-19 Exercise |
2020-06-23 4:10 pm |
N/A 2026-11-21 |
Blueprint Medicines Corp | BPMC | Dorsch Marion Chief Scientific Officer |
4,600 | $0 | 77,050 (Direct) |
View |